Keith Fox in conversation with Thomas Luscher
ROCKET AF: Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation

Kenneth Ellenbogen in conversation with Frank Ruschitzka
Primary Results from the SMART AV Trial: A Randomized Trial Comparing Empiric, Echocardiographic Guided and Algorithmic AV Delay Programming in Cardiac Resynchronization Therapy (CRT)

Keith Aaronson in conversation with Frank Ruschitzka
ADVANCE Bridge to Transplant Trial: Evaluation of the HeartWare HVAD Left Ventricular Assist System for the Treatment of Advanced Heart Failure

Anthony Tang in conversation with Frank Ruschitzka
RAFT: The Resynchronization/Defibrillation for Ambulatory Heart Failure Trial

Adrian Hernandez in conversation with Frank Ruschitzka
ASCEND-HF: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial

Frank Zannad in conversation with Frank Ruschitzka
EMPHASIS-HF: The effect of eplerenone versus placebo on cardiovascular mortality or heart failure hospitalization in subjects with NYHA class II chronic systolic heart failure.

Otavio Bellwanger in conversation with Ulf Landmesser
ACT: Acetylcystein for the Prevention of Contract-Induced nephropaThy

Christoph Kaiser in conversation with Thomas Luscher
BASKET PROVE: the BASKET PROspective Evaluation Examination (BASKET PROVE)

Stephen Nicholls in conversation with Ulf Landmesser
Results of the First Major Clinical Trial of an Oral Agent Inducing Apo A1 Synthesis: A New Approach to HDL Raising and CVR Risk Modification

Peter Kowey in conversation with Ulf Landmesser
Efficacy and Safety of Prescription Omega-3-Acid Ethyl Esters (P-OM3) for the Prevention of Recurrent Symptomatic Atrial Fibrillation (AF)